Corrigendum to “Integrated population pharmacokinetics of immunoglobulin G following intravenous or subcutaneous administration of various immunoglobulin products in patients with primary immunodeficiencies” [Int. Immunopharmacol. 113(Part A) (2022) 109331]

Saved in:
Bibliographic Details
Published in:International immunopharmacology 2023-01, Vol.114, p.109555, Article 109555
Main Authors: Li, Zhaoyang, Follman, Kristin, Freshwater, Ed, Engler, Frank, Yel, Leman
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue
container_start_page 109555
container_title International immunopharmacology
container_volume 114
creator Li, Zhaoyang
Follman, Kristin
Freshwater, Ed
Engler, Frank
Yel, Leman
description
doi_str_mv 10.1016/j.intimp.2022.109555
format article
fullrecord <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1016_j_intimp_2022_109555</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1567576922010402</els_id><sourcerecordid>S1567576922010402</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2025-a71c32e54f293bc15f1bb495e7330591f1b231f90a79391f1fc91dcb8aeb293b3</originalsourceid><addsrcrecordid>eNp9UU1v1DAQTREVLS3_ACEf20OCHa-TzQWpWkFZqRIc4FRVkeNMtl4SO_LHVtz6Q-DP9Zcw2Ww5cOBgeWbee-PxvCR5y2jGKCvebzNtgh7GLKd5jqVKCPEiOWXLcpmykoqXGIuiTEVZVCfJa--3lGJ9wV4lJ7wQebksi9Oj45V1Tm_AtHEgwZKnx19rE2DjZICWjHaMvQzaGjLeSzdIZX9oA0ErT2xH9DBEYze9bWKvDbkmne17-6DNhuBsTu7A2IhMR3xsVAzSwJTLdtBGeyTsO2OjnXR6Qv5pODrbRhWwjjGSwWD8oMM9InqQ7udB0EKnFaJ4_NPjb3KLX8jIeo89z91nhDF-8VW6QK4uycW0tUuCa-Oc3Z0nx53sPbw53GfJ908fv60-pzdfrterq5tUIV2ksmSK5yAWXV7xRjHRsaZZVAJKzqmoGKY5Z11FZVnxKe1UxVrVLCU0k4KfJYu5r3LWewddffhIzWg9uVpv69nVepqvnl1F2btZNsZmgPav6NlGJHyYCYDD7zS42u_3Aa12oELdWv3_F_4Ar--9XQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Corrigendum to “Integrated population pharmacokinetics of immunoglobulin G following intravenous or subcutaneous administration of various immunoglobulin products in patients with primary immunodeficiencies” [Int. Immunopharmacol. 113(Part A) (2022) 109331]</title><source>Elsevier</source><creator>Li, Zhaoyang ; Follman, Kristin ; Freshwater, Ed ; Engler, Frank ; Yel, Leman</creator><creatorcontrib>Li, Zhaoyang ; Follman, Kristin ; Freshwater, Ed ; Engler, Frank ; Yel, Leman</creatorcontrib><identifier>ISSN: 1567-5769</identifier><identifier>EISSN: 1878-1705</identifier><identifier>DOI: 10.1016/j.intimp.2022.109555</identifier><identifier>PMID: 36527876</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><ispartof>International immunopharmacology, 2023-01, Vol.114, p.109555, Article 109555</ispartof><rights>2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36527876$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Li, Zhaoyang</creatorcontrib><creatorcontrib>Follman, Kristin</creatorcontrib><creatorcontrib>Freshwater, Ed</creatorcontrib><creatorcontrib>Engler, Frank</creatorcontrib><creatorcontrib>Yel, Leman</creatorcontrib><title>Corrigendum to “Integrated population pharmacokinetics of immunoglobulin G following intravenous or subcutaneous administration of various immunoglobulin products in patients with primary immunodeficiencies” [Int. Immunopharmacol. 113(Part A) (2022) 109331]</title><title>International immunopharmacology</title><addtitle>Int Immunopharmacol</addtitle><issn>1567-5769</issn><issn>1878-1705</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9UU1v1DAQTREVLS3_ACEf20OCHa-TzQWpWkFZqRIc4FRVkeNMtl4SO_LHVtz6Q-DP9Zcw2Ww5cOBgeWbee-PxvCR5y2jGKCvebzNtgh7GLKd5jqVKCPEiOWXLcpmykoqXGIuiTEVZVCfJa--3lGJ9wV4lJ7wQebksi9Oj45V1Tm_AtHEgwZKnx19rE2DjZICWjHaMvQzaGjLeSzdIZX9oA0ErT2xH9DBEYze9bWKvDbkmne17-6DNhuBsTu7A2IhMR3xsVAzSwJTLdtBGeyTsO2OjnXR6Qv5pODrbRhWwjjGSwWD8oMM9InqQ7udB0EKnFaJ4_NPjb3KLX8jIeo89z91nhDF-8VW6QK4uycW0tUuCa-Oc3Z0nx53sPbw53GfJ908fv60-pzdfrterq5tUIV2ksmSK5yAWXV7xRjHRsaZZVAJKzqmoGKY5Z11FZVnxKe1UxVrVLCU0k4KfJYu5r3LWewddffhIzWg9uVpv69nVepqvnl1F2btZNsZmgPav6NlGJHyYCYDD7zS42u_3Aa12oELdWv3_F_4Ar--9XQ</recordid><startdate>202301</startdate><enddate>202301</enddate><creator>Li, Zhaoyang</creator><creator>Follman, Kristin</creator><creator>Freshwater, Ed</creator><creator>Engler, Frank</creator><creator>Yel, Leman</creator><general>Elsevier B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>202301</creationdate><title>Corrigendum to “Integrated population pharmacokinetics of immunoglobulin G following intravenous or subcutaneous administration of various immunoglobulin products in patients with primary immunodeficiencies” [Int. Immunopharmacol. 113(Part A) (2022) 109331]</title><author>Li, Zhaoyang ; Follman, Kristin ; Freshwater, Ed ; Engler, Frank ; Yel, Leman</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2025-a71c32e54f293bc15f1bb495e7330591f1b231f90a79391f1fc91dcb8aeb293b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Li, Zhaoyang</creatorcontrib><creatorcontrib>Follman, Kristin</creatorcontrib><creatorcontrib>Freshwater, Ed</creatorcontrib><creatorcontrib>Engler, Frank</creatorcontrib><creatorcontrib>Yel, Leman</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><jtitle>International immunopharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Li, Zhaoyang</au><au>Follman, Kristin</au><au>Freshwater, Ed</au><au>Engler, Frank</au><au>Yel, Leman</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Corrigendum to “Integrated population pharmacokinetics of immunoglobulin G following intravenous or subcutaneous administration of various immunoglobulin products in patients with primary immunodeficiencies” [Int. Immunopharmacol. 113(Part A) (2022) 109331]</atitle><jtitle>International immunopharmacology</jtitle><addtitle>Int Immunopharmacol</addtitle><date>2023-01</date><risdate>2023</risdate><volume>114</volume><spage>109555</spage><pages>109555-</pages><artnum>109555</artnum><issn>1567-5769</issn><eissn>1878-1705</eissn><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>36527876</pmid><doi>10.1016/j.intimp.2022.109555</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1567-5769
ispartof International immunopharmacology, 2023-01, Vol.114, p.109555, Article 109555
issn 1567-5769
1878-1705
language eng
recordid cdi_crossref_primary_10_1016_j_intimp_2022_109555
source Elsevier
title Corrigendum to “Integrated population pharmacokinetics of immunoglobulin G following intravenous or subcutaneous administration of various immunoglobulin products in patients with primary immunodeficiencies” [Int. Immunopharmacol. 113(Part A) (2022) 109331]
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T17%3A08%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Corrigendum%20to%20%E2%80%9CIntegrated%20population%20pharmacokinetics%20of%20immunoglobulin%20G%20following%20intravenous%20or%20subcutaneous%20administration%20of%20various%20immunoglobulin%20products%20in%20patients%20with%20primary%20immunodeficiencies%E2%80%9D%20%5BInt.%20Immunopharmacol.%20113(Part%20A)%20(2022)%20109331%5D&rft.jtitle=International%20immunopharmacology&rft.au=Li,%20Zhaoyang&rft.date=2023-01&rft.volume=114&rft.spage=109555&rft.pages=109555-&rft.artnum=109555&rft.issn=1567-5769&rft.eissn=1878-1705&rft_id=info:doi/10.1016/j.intimp.2022.109555&rft_dat=%3Celsevier_cross%3ES1567576922010402%3C/elsevier_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2025-a71c32e54f293bc15f1bb495e7330591f1b231f90a79391f1fc91dcb8aeb293b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/36527876&rfr_iscdi=true